Zhou, X. (2023). Tumor biomarkers that identify molecular subtypes and best responders to chemotherapy in patients with PDAC. https://doi.org/10.11588/heidok.00032941
Chicago Style (17th ed.) CitationZhou, Xu. Tumor Biomarkers That Identify Molecular Subtypes and Best Responders to Chemotherapy in Patients with PDAC. Heidelberg, 2023. https://doi.org/10.11588/heidok.00032941.
MLA (9th ed.) CitationZhou, Xu. Tumor Biomarkers That Identify Molecular Subtypes and Best Responders to Chemotherapy in Patients with PDAC. 2023. https://doi.org/10.11588/heidok.00032941.
Warning: These citations may not always be 100% accurate.